Advertisement

Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis

      Abstract

      Background

      Topical antibiotics have been shown to reduce exit-site infection and peritonitis. The aim of this study was to compare infection rates between mupirocin and gentamicin.

      Methods

      Multiple comprehensive databases were searched systematically to include relevant randomized controlled trials and observational studies. Pooled risk ratios (RRs) and 95% confidence intervals were calculated for the incidences of exit-site infection and peritonitis.

      Results

      Seven studies (mupirocin group n = 458, gentamicin group n = 448) were analyzed for exit-site infection. The risk of gram-positive exit-site infection was similar between the groups. Gram-negative exit-site infection rate was higher in the mupirocin group (RR = 2.125, P = 0.037). Six studies were assessed the peritonitis risk. There was no difference in the gram-positive and -negative peritonitis rate.

      Conclusions

      Topical use of gentamicin is associated with fewer exit-site infections caused by gram-negative organisms. Gentamicin has comparable efficacy to mupirocin for peritonitis and gram-positive exit-site infection.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Laurin L.P.
        • Harrak H.
        • Elftouh N.
        • et al.
        Outcomes of infection-related hospitalization according to dialysis modality.
        Clin J Am Soc Nephrol. 2015; 10: 817-824
        • Tsai C.C.
        • Lee J.J.
        • Liu T.P.
        • et al.
        Effects of age and diabetes mellitus on clinical outcomes in patients with peritoneal dialysis-related peritonitis.
        Surg Infect (Larchmt). 2013; 14: 540-546
        • Cho Y.
        • Johnson D.W.
        Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes.
        Am J Kidney Dis. 2014; 64: 278-289
        • Piraino B.
        • Bernardini J.
        • Brown E.
        • et al.
        ISPD position statement on reducing the risks of peritoneal dialysis-related infections.
        Perit Dial Int. 2011; 31: 614-630
        • Warady B.A.
        • Bakkaloglu S.
        • Newland J.
        • et al.
        Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.
        Perit Dial Int. 2012; 2: S32-S86
        • Xu G.
        • Tu W.
        • Xu C.
        Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis.
        Nephrol Dial Transpl. 2010; 25: 587-592
        • Nair R.
        • Perencevich E.N.
        • Blevins A.E.
        • et al.
        Clinical effectiveness of mupirocin for preventing staphylococcus aureus infections in nonsurgical settings: a meta-analysis.
        Clin Infect Dis. 2016; 62: 618-630
        • Szeto C.C.
        • Chow K.M.
        Gram-negative peritonitis–the Achilles heel of peritoneal dialysis?.
        Perit Dial Int. 2007; 2: S267-S271
        • Bernardini J.
        • Bender F.
        • Florio T.
        • et al.
        Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
        J Am Soc Nephrol. 2005; 16: 539-545
        • Chu K.H.
        • Choy W.Y.
        • Cheung C.C.
        • et al.
        A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections.
        Perit Dial Int. 2008; 28: 505-508
        • Pierce D.A.
        • Williamson J.C.
        • Mauck V.S.
        • et al.
        The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis.
        Perit Dial Int. 2012; 32: 525-530
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • Altman D.G.
        PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        BMJ. 2009; 339: b2535
        • Cheng S.P.
        • Liu T.P.
        • Yang P.S.
        • et al.
        Effect of perioperative dexamethasone on subjective voice quality after thyroidectomy: a meta-analysis and systematic review.
        Langenbecks Arch Surg. 2015; 400: 929-936
        • Higgins J.P.
        • Altman D.G.
        • Gotzsche P.C.
        • et al.
        • Cochrane Bias Methods Group
        • Cochrane Statistical Methods Group
        The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
        BMJ. 2011; 343: d5928
        • Wells G.A.
        • Shea B.
        • Higgins J.P.
        • et al.
        Checklists of methodological issues for review authors to consider when including non-randomized studies in systematic reviews.
        Res Synth Methods. 2013; 4: 63-77
        • Chang Y.C.
        • Liu C.L.
        • Liu T.P.
        • et al.
        Effect of perioperative intravenous lidocaine infusion on acute and chronic pain after breast surgery: a meta-analysis of randomized controlled trials.
        Pain Pract. 2017; 17: 336-343
        • Cheng S.P.
        • Lee J.J.
        • Liu T.P.
        • et al.
        Quality of life after surgery or surveillance for asymptomatic primary hyperparathyroidism: a meta-analysis of randomized controlled trials.
        Med Baltim. 2015; 94: e931
        • Mortazavi M.
        • Halabian M.
        • Seyrafian S.
        • et al.
        Is there any difference between use of gentamycin and mupirocin ointments in decrease exit site infection ratio in peritoneal dialysis patients?.
        Iran J Kidney Dis. 2011; 2: 64
        • Al-Hwiesh A.K.
        • Abdul-Rahman I.S.
        • Al-Muhanna F.A.
        • et al.
        Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
        Int J Artif Organs. 2013; 36: 473-483
        • Mahaldar A.
        • Weisz M.
        • Kathuria P.
        Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
        Adv Perit Dial. 2009; 25: 56-59
        • Davenport A.
        Pan Thames Renal Audit Peritoneal Dialysis Group. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? the pan thames renal audit.
        J Nephrol. 2012; 25: 819-824
        • Wu K.
        • Greanya E.
        • Shalansky K.
        • et al.
        Comparison of gentamicin ointment to mupirocin ointment for prevention of peritoneal dialysis catheter-related infections.
        Curr Drug Ther. 2013; 8: 38-44
        • Chen S.S.
        • Sheth H.
        • Piraino B.
        • Bender F.
        Long-term exit-site gentamicin prophylaxis and gentamicin resistance in a peritoneal dialysis program.
        Perit Dial Int. 2016; 36: 387-389
        • Ho K.C.
        • Lee J.J.
        • Liu T.P.
        • et al.
        Influence of dialysis modalities on patients undergoing parathyroidectomy for renal hyperparathyroidism.
        Formos J Surg. 2015; 48: 151-156
        • Li P.K.
        • Chow K.M.
        Infectious complications in dialysis–epidemiology and outcomes.
        Nat Rev Nephrol. 2011; 8: 77-88
        • Li P.K.
        • Szeto C.C.
        • Piraino B.
        • et al.
        International Society for Peritoneal Dialysis. Peritoneal dialysis-related infections recommendations: 2010 update.
        Perit Dial Int. 2010; 30: 393-423
        • van Diepen A.T.
        • Tomlinson G.A.
        • Jassal S.V.
        The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients.
        Clin J Am Soc Nephrol. 2012; 7: 1266-1271
        • Lloyd A.
        • Tangri N.
        • Shafer L.A.
        • et al.
        The risk of peritonitis after an exit site infection: a time-matched, case-control study.
        Nephrol Dial Transpl. 2013; 28: 1915-1921
        • Chang C.S.
        • Chen H.H.
        • Liu H.C.
        • Wu C.J.
        Early surgical intervention of peritoneal dialysis catheter-related Pseudomonas peritonitis.
        South Med J. 2011; 104: 373-374
        • Khan W.
        • Bernier S.P.
        • Kuchma S.L.
        • et al.
        Aminoglycoside resistance of Pseudomonas aeruginosa biofilms modulated by extracellular polysaccharide.
        Int Microbiol. 2010; 13: 207-212
        • Wong P.N.
        • Tong G.M.
        • Wong Y.Y.
        • et al.
        Alternating mupirocin/gentamicin is associated with increased risk of fungal peritonitis as compared with gentamicin alone - results of a randomized open-label controlled trial.
        Perit Dial Int. 2016; 36: 340-346
        • McQuillan R.F.
        • Chiu E.
        • Nessim S.
        • et al.
        A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.
        Clin J Am Soc Nephrol. 2012; 7: 297-303
        • Johnson D.W.
        • Badve S.V.
        • Pascoe E.M.
        • et al.
        • HONEYPOT Study Collaborative Group
        Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial.
        Lancet Infect Dis. 2014; 14: 23-30